Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | GBA1 | P04062 | 1/20 | 0.39 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15703305 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL123831 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL16390022 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL16389920 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL2042635 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL2041621 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL16390519 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL2041646 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL2037635 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL284336 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 311 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116023548-B | External electron donor composition, application thereof, catalyst system and olefin polymerization method | 中国石油化工股份有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-116023555-B | External electron donor, application thereof, catalyst system for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2024-08-02 | — | — | CN | claimed |
| EP-2621867-B1 | BIOSTATIC NEUTRALIZING COMPOSITION FOR AQUEOUS FLUIDS | ARKEMA FRANCE (FR) | 2018-04-18 | — | — | EP | claimed |
| US-9232789-B2 | Biostatic neutralizing composition for aqueous fluids | ARKEMA FRANCE (FR) | 2016-01-12 | — | — | US | claimed |
| US-20130217780-A1 | Biostatic Neutralizing Composition for Aqueous Fluids | ARKEMA FRANCE (FR) | 2013-08-22 | — | — | US | claimed |
| EP-2621867-A1 | BIOSTATIC NEUTRALIZING COMPOSITION FOR AQUEOUS FLUIDS | Arkema France (FR) | 2013-08-07 | — | — | EP | claimed |
| WO-2012045958-A1 | BIOSTATIC NEUTRALIZING COMPOSITION FOR AQUEOUS FLUIDS | ARKEMA FRANCE (FR) | 2012-04-12 | — | — | WO | claimed |
| CN-116023548-B | External electron donor composition, application thereof, catalyst system and olefin polymerization method | 中国石油化工股份有限公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-116023555-B | External electron donor, application thereof, catalyst system for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2024-08-02 | — | — | CN | disclosed |
| US-11965142-B2 | Lubricating oil composition | IDEMITSU KOSAN CO., LTD. (JP) | 2024-04-23 | — | — | US | disclosed |
| EP-3950905-B1 | LUBRICATING OIL COMPOSITION | IDEMITSU KOSAN CO (JP) | 2024-01-17 | — | — | EP | disclosed |
| CN-116023548-A | External electron donor composition, application thereof, catalyst system and olefin polymerization method | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-116023555-A | External electron donor, application thereof, catalyst system for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | disclosed |
| US-6656887-B2 | Metal salt or amine salt of thiophosphate or of phosphate are decreased in sulfur content and excellent in the ability to maintain the total base number | NIPPON MITSUBISHI OIL CORPORATION (JP) | 2003-12-02 | — | — | US | disclosed |
| US-20020142922-A1 | Lubricating oil compositions | NIPPON MITSUBISHI OIL CORPORATION | 2002-10-03 | — | — | US | disclosed |
| EP-1227145-A1 | Lubricating oil compositions | Nippon Mitsubishi Oil Corporation (JP) | 2002-07-31 | — | — | EP | disclosed |
| EP-0323163-B1 | SHIFT-FEEL DURABILITY ENHANCEMENT | ETHYL PETROLEUM ADDITIVES, INC. (US) | 1991-05-29 | — | — | EP | disclosed |
| EP-0323163-A1 | Shift-feel Durability enhancement | ETHYL PETROLEUM ADDITIVES, INC. (US) | 1989-07-05 | — | — | EP | disclosed |
| US-4795583-A | FRICTION MODIFIER FOR AUTOMATIC TRANSMISSION FLUIDS CONTAINING AN ALIPHATIC TERTIARY AMINE, ALIPHATIC DIAMINE AND-OR N-SUBSTITUTED DIALKANOLAMINE | ETHYL PETROLEUM ADDITIVES, INC. (US) | 1989-01-03 | — | — | US | disclosed |
| US-3954846-A | New quaternary ammonium salts of malic acid and their application in cosmetics | AGENCE NATIONALE DE VALORIZATION DE LA RECHERCHE (ANVAR) (FR) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130217780-A1 | Biostatic Neutralizing Composition for Aqueous Fluids | MME, NEFM, COMT | DNM1 729/4885SPHK1 3034/4885CA12 239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.